Fundraising Fox

Christopher de Souza

Investor

Director, Biopharma Team at Broadview Ventures

Boston, Massachusetts, United States

About

Director on the Biopharma team with 40+ years in cardiovascular and metabolic research, biopharma R&D, and business development. Formerly at Novartis and SkyePharma US.

Contact· published on Christopher's own website

Experience

  1. Broadview VenturesDirectorcurrent2012 — presentGreater Boston Area
  2. Longview VenturesDirectorcurrent2019 — presentBoston, Massachusetts, United States
  3. Gila TherapeuticsBoard Director2016 — 2025Greater Minneapolis-St. Paul Area
  4. Pulmokine IncBoard Observer2015 — 2024Rensselaer, NY
  5. Mellitus, LLCBoard Director2017 — 2024Greater Boston Area
  6. Acesion PharmaBoard Observer2014 — 2024Copenhagen Area, Denmark
  7. MassBioBoard Director2016 — 2021Boston, Massachusetts, United States
  8. Giner Life SciencesMember, Board of Director2019 — 2021Greater Boston Area
  9. British Heart FoundationChair, Translation Awards Committee2018 — 2021London, United Kingdom
  10. Allosteros Therapeutics Inc.Board Observer2012 — 2019San Francisco Bay Area
  11. CellAegis Devices Inc.Board Observer2012 — 2019Toronto, Canada Area
  12. Metaome Science Informatics Pvt LtdStrategic Advisor and BOD member2010 — 2017
  13. Laurantis PharmaBoard Observer2012 — 2014Helsinki Area, Finland
  14. Diagnostics for AllBusiness Development Consultant2010 — 2012Cambridge, MA
  15. Mass Biotech CouncilCo-Chair, Business Development Committee2004 — 2012
  16. SkyePharmaVP Business Development2007 — 2010Greater Boston Area
  17. NovartisDirector, Strategic Alliances2000 — 2006
  18. NovartisSenior Scientist1995 — 2000New Jersey

Skills & more

Start-ups20Strategic Planning11Venture Capital8Biopharmaceuticals14Biotechnology48Product Development3Medical Devices10Due Diligence5Emerging Markets4Business Development15Pharmaceutical Industry24Lifesciences17
+10 moreMergersStrategyDiabetesLicensingNegotiationClinical ResearchStrategic AlliancesCommercializationProgram ManagementInfectious Diseases

From Christopher's professional profile.

Colleagues at Broadview Ventures

Frequently asked questions

Who is Christopher de Souza?
Director on the Biopharma team with 40+ years in cardiovascular and metabolic research, biopharma R&D, and business development. Formerly at Novartis and SkyePharma US.
Where does Christopher de Souza work?
Christopher de Souza is Director, Biopharma Team at Broadview Ventures.
Where did Christopher de Souza go to school?
Christopher de Souza studied at Rutgers University–Newark (MBA, Management); Louisiana State University (MS and PhD, Endocrine Physiology); University of Mumbai (BSc and MSc, Zoology and Biochemistry).

Same school

Shared employers